stocktools
Dilution profile // every instrument, one screen, from SEC filings

Ginkgo Bioworks Holdings, Inc. (DNA)

CIK 1830214 · all EDGAR filings →

Overall dilution risk
HIGHworst of 2 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$500M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
NOT COMPUTEDunder 3 years of share history on file
= share count now vs 3 years ago
Cash need
HIGH~5.9 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Fewer than two cover-page share counts on file, so there is no history to chart.

Cash runway

~6 months of cash left

critical · burning $42.8M / quarter

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 524,540 underlying shares, as reported Dec 31, 2021 (10-K).

Balance-sheet fair value of warrants: $5.7M as of Dec 31, 2023.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 6, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $500.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3Aug 7, 2025$500.0M registeredfiling →
S-3May 9, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-3Aug 23, 2023no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 1 executed · 0 registered.

EXECUTEDSep 4, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EFFECTIVEAug 14, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDAug 7, 2025S-3 registration — capacity to sell shares, not a sale yetS-3 →
UPDATEMay 17, 2024Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEMay 17, 2024SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMay 9, 2024S-3 registration — capacity to sell shares, not a sale yetS-3 →
UPDATEAug 29, 2023Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEAug 29, 2023SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDAug 23, 2023S-3 registration — capacity to sell shares, not a sale yetS-3 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full DNA workspace